CerFlux
Birmingham
About CerFlux
CerFlux offers personalized medicine technology for matching treatments to tumors that aim to improve outcomes and quality of life while reducing the time, the pain, and the cost of cancer treatment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $375.0K
- Last round: Grant (Aug 2023)
- Website: cerflux.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Medical, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/cerflux-187671 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.